EGLU

Source: Wikipedia, the free encyclopedia.
EGLU
Identifiers
  • (2S)-2-Amino-2-ethylpentanedioic acid
JSmol)
  • O=C(O)CC[C@](N)(C(=O)O)CC
  • InChI=1S/C7H13NO4/c1-2-7(8,6(11)12)4-3-5(9)10/h2-4,8H2,1H3,(H,9,10)(H,11,12)/t7-/m0/s1 ☒N
  • Key:QFYBYZLHPIALCZ-ZETCQYMHSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

EGLU ((2S)-α-ethylglutamic acid ) is a drug that is used in neuroscience research. It was one of the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR2/3), and so has been useful in the characterization and study of this receptor subfamily.[1][2][3][4][5][6][7]

References

This page is based on the copyrighted Wikipedia article: EGLU. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy